Thomas W Stone MD
Retinal Disease
Retina Associates of Kentucky, Managing Partner, Louisville Office
Join to View Full Profile
6450 Dutchmans ParkwayLouisville, KY 40205
Phone+1 800-627-2020
Dr. Stone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Stone is an ophthalmologist based in Louisville, KY, specializing in retinal disease, with expertise in vitreoretinal disease. He completed his ophthalmology residency at Duke University Hospital and his medical education at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. Dr. Stone has contributed significantly to clinical ophthalmology through his published research, with multiple articles on macular degeneration and diabetic macular edema, some of which have been extensively cited. He has also been involved in clinical trials related to diabetes and ophthalmology. His honors include the CMS Meaningful Use Stage 1 Certification and fellow status with the American Academy of Ophthalmology.
Education & Training
Duke University HospitalResidency, Ophthalmology, 1996 - 1999
University at BuffaloInternship, Internal Medicine, 1995 - 1996- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1995
Certifications & Licensure
IN State Medical License 2016 - 2027
KY State Medical License 2002 - 2026
WV State Medical License 2013 - 2015
NC State Medical License 1999 - 2007
GA State Medical License 2000 - 2005
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow American Society of Retina Specialists (FASRS) American Society of Retina Specialists
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
Publications & Presentations
PubMed
- 7 citationsConsolidation of Imaging Modalities Utilizing Digitally Assisted Visualization Systems: The Development of a Surgical Information Handling Cockpit.Cassandra C Brooks, John W. Kitchens, Thomas W Stone, Christopher D. Riemann
Clinical Ophthalmology. 2020-02-27 - 41 citationsNatural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
Ophthalmology. 2019-02-01 - 150 citationsProgression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.Tiarnan D L Keenan, Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten
Ophthalmology. 2018-12-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Retina Associates of Kentucky (3)February 22nd, 2017
Committees
- Co-Chair, Medical Executive Board, Education Committee 2022 - 2025
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
